Jci_page_head_homepage_01 Jci_page_head_homepage_02
Veronica Marrella, Pietro Luigi Poliani, Anna Casati, Francesca Rucci, Laura Frascoli, Marie-Lise Gougeon, Brigitte Lemercier, Marita Bosticardo, Maria Ravanini, Manuela Battaglia, Maria Grazia Roncarolo, Marina Cavazzana-Calvo, Fabio Facchetti, Luigi D. Notarangelo, Paolo Vezzoni, Fabio Grassi, Anna Villa
Published in Volume 117, Issue 5
J Clin Invest. 2007; 117(5):1260–1269 doi:10.1172/JCI30928
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Impaired B cell development in Rag2R229Q/R229Q mice.

(A) Top: Relative representation and SD of B220low and B220high cells in the bone marrow of the indicated mice (n = 6). Bottom: Dot-plot analysis of bone marrow cells from the indicated mice labeled with B220 and CD2 antibodies and IgD and IgM expression of electronically gated B220+ bone marrow cells. (B) Top: Relative representation and SD of B220+ cells in the spleens of the indicated mice (n = 6). Bottom: Dot-plot analysis of B220+ splenocytes labeled with CD21 and CD23 antibodies or IgD and IgM antibodies. P values were determined by unpaired Student’s t test. Numbers indicate the percentage of cells in the indicated gates.